Orbsen Therapeutics Ltd. — Form D

Orbsen Therapeutics Ltd. of GALWAY, L2, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-26. The offering totals $3.7M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2017-07-26
• Form: D
• Accession: 0001712617-17-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $3.7M
• Amount sold: $1.3M
• Remaining: $2.4M
• Minimum investment: $50K
• Investors: 11
• Date of first sale: 2017-01-19
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-291532

Issuer

• Name: Orbsen Therapeutics Ltd.
• CIK: 0001712617
• Entity type: Limited Liability Company
• Jurisdiction: IRELAND
• Address: ORBSEN BUILDING, GALWAY, L2, H91DK59
• Phone: 353 91 528778

Officers, directors & promoters (10)

More

• CIK 1712617 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search